| Preemptive pharmacogenetic testing: exploring the knowledge and perspectives of US payers NJ Keeling, MM Rosenthal, D West-Strum, AS Patel, CE Haidar, ... Genetics in Medicine 21 (5), 1224-1232, 2019 | 71 | 2019 |
| Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward KE Caudle, NJ Keeling, TE Klein, M Whirl-Carrillo, VM Pratt, JM Hoffman Pharmacogenomics 19 (10), 847-860, 2018 | 64 | 2018 |
| Priorities for pediatric patient safety research JM Hoffman, NJ Keeling, CB Forrest, HL Tubbs-Cooley, E Moore, ... Pediatrics 143 (2), 2019 | 44 | 2019 |
| PARC report: a health-systems focus on reimbursement and patient access to pharmacogenomics testing S L Rogers, NJ Keeling, J Giri, N Gonzaludo, JS Jones, E Glogowski, ... Pharmacogenomics 21 (11), 785-796, 2020 | 20 | 2020 |
| Approaches to assessing the provider experience with clinical pharmacogenomic information: A scoping review NJ Keeling, TJ Dunn, JP Bentley, S Ramachandran, JM Hoffman, ... Genetics in Medicine 23 (9), 1589-1603, 2021 | 4 | 2021 |
| A Sustainable Future In The Implementation Of Clinical Pharmacogenomics N Keeling | | 2019 |
| AMCP Partnership Forum: Managing Care in the Wave of Precision Medicine R Anhorn, K Ashcraft, M Beattie, E Berliner, K Bordenave, P Bourne, ... JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY 24 (7), 583-588, 2018 | | 2018 |
| Payer Perspectives On Preemptive Pharmacogenetic Testing N Keeling | | 2016 |
